Liaoning He Eye Hospital Group (301103) Fair Value & Analysis
Healthcare · CN · Market cap 2.5B CNY
Fair value as of: Jun 24, 2026
Analysis
Liaoning He Eye Hospital Group (301103) currently trades at ¥16.02, while our model-based Fair Value estimate is ¥7.57 — implying the stock looks roughly 52.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Liaoning He Eye Hospital Group Co., LTD. provides ophthalmic specialist diagnosis, treatment, and optometry services to patients with eye diseases. It offers cataract diagnosis and treatment, refractive error surgical correction, vitreoretinal diagnosis and treatment, other surgical diagnosis and treatment services, etc. The company also provides refractive cataracts, LASIK surgery, myopia prevention, medical fitting, diabetic retinopathy, dry eyes and cornea, gene diagnosis, and comprehensive eye disease solutions. Liaoning He Eye Hospital Group Co., LTD. was founded in 1995 and is based in Shenyang, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Liaoning He Eye Hospital Group (301103) undervalued?
What is the fair value of 301103?
What is the quality score of 301103?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.